retatrutide phase 2 study results Safety, Side Effects & Provider Use 🚨 Retatrutide Phase 2 is

Patients should be aware that tirzepatide may reduce the effectiveness of oral contraceptives, particularly after initiation and dose increases

These medications work by reducing hunger, slowing stomach emptying, and altering food preferences, which can lead to lower calorie intake and, in some cases, unintended side effects such as nausea, constipation, and loss of lean muscle mass

,

By Graeme Walker Excellent service

Retatrutide is a triple-hormone receptor agonist from Eli Lilly that produced 2428% average weight loss in Phase 2 trials, significantly exceeding the 1215% typical of semaglutide and the 1522% of tirzepatide